BR9106166A - Uso de cetorolac para o tratamento de doenca periodontal - Google Patents

Uso de cetorolac para o tratamento de doenca periodontal

Info

Publication number
BR9106166A
BR9106166A BR919106166A BR9106166A BR9106166A BR 9106166 A BR9106166 A BR 9106166A BR 919106166 A BR919106166 A BR 919106166A BR 9106166 A BR9106166 A BR 9106166A BR 9106166 A BR9106166 A BR 9106166A
Authority
BR
Brazil
Prior art keywords
treatment
periodontal disease
cetorolac
ketorolac
prevention
Prior art date
Application number
BR919106166A
Other languages
English (en)
Inventor
Gary Robert Kelm
Harvey Marvin Pickrum
Matthew Joseph Doyle
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9106166A publication Critical patent/BR9106166A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR919106166A 1990-03-16 1991-03-01 Uso de cetorolac para o tratamento de doenca periodontal BR9106166A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49469790A 1990-03-16 1990-03-16
US65106191A 1991-02-08 1991-02-08
PCT/US1991/001441 WO1991013609A1 (en) 1990-03-16 1991-03-01 Use of ketorolac for treatment of periodontal disease

Publications (1)

Publication Number Publication Date
BR9106166A true BR9106166A (pt) 1993-03-16

Family

ID=27051510

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106166A BR9106166A (pt) 1990-03-16 1991-03-01 Uso de cetorolac para o tratamento de doenca periodontal

Country Status (14)

Country Link
EP (1) EP0519983B1 (pt)
JP (1) JP3140050B2 (pt)
AT (1) ATE137967T1 (pt)
AU (1) AU661818B2 (pt)
BR (1) BR9106166A (pt)
CA (1) CA2077693C (pt)
DE (1) DE69119588T2 (pt)
DK (1) DK0519983T3 (pt)
ES (1) ES2086536T3 (pt)
GR (1) GR3019928T3 (pt)
IE (1) IE910886A1 (pt)
NZ (1) NZ237449A (pt)
SG (1) SG54157A1 (pt)
WO (1) WO1991013609A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
DE4300697C1 (de) * 1993-01-13 1994-05-19 Roemmers Sa Keterolac-Derivat mit wesentlich geringerer gastrointestinaler Reizung und Ulzeration
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5807541A (en) * 1996-04-22 1998-09-15 Sepracor, Inc. NSAID/fluoride periodontal compositions and methods
BRPI0302736B8 (pt) 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US7732478B2 (en) 2004-01-09 2010-06-08 The Trustees Of Columbia University In The City Of New York Methods for facilitating metabolic control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5238030A (en) * 1975-07-04 1977-03-24 Gaba Ag Mouth and tooth reparing agent
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
DK174702B1 (da) * 1987-09-11 2003-09-29 Syntex Llc Konserveringssystem til ophthalmiske formuleringer
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease

Also Published As

Publication number Publication date
JPH05505400A (ja) 1993-08-12
WO1991013609A1 (en) 1991-09-19
CA2077693C (en) 1997-03-04
SG54157A1 (en) 1998-11-16
DE69119588D1 (de) 1996-06-20
EP0519983A4 (en) 1993-03-10
CA2077693A1 (en) 1991-09-17
NZ237449A (en) 1996-10-28
ES2086536T3 (es) 1996-07-01
JP3140050B2 (ja) 2001-03-05
IE910886A1 (en) 1991-09-25
AU7472991A (en) 1991-10-10
EP0519983A1 (en) 1992-12-30
ATE137967T1 (de) 1996-06-15
AU661818B2 (en) 1995-08-10
DK0519983T3 (da) 1996-10-14
DE69119588T2 (de) 1996-11-21
EP0519983B1 (en) 1996-05-15
GR3019928T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
BR9106864A (pt) Composicoes de liberacao prolongada para o tratamento de doencas periodontais
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
ES2025057B3 (es) Agente para la higiene bucal.
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
IT1302365B1 (it) Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
KR950702405A (ko) 구강 조성물(oral compositions)
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
BR9106166A (pt) Uso de cetorolac para o tratamento de doenca periodontal
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR9506956A (pt) Composição farmacêutica antitussígena
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
FI945866L (fi) Ennaltaehkäisevä ja hoitava valmiste kariesta vastaan
PT1049461E (pt) Uso de preparacoes topicas de trinitrato de glicerilo e lanolina para o tratamento da disfuncao erectil
SE8004592L (sv) Tandkrem
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
BR9701455A (pt) Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
DAWBER ORAL TIUSORALEN THERAPY IN VITILIGO
NO970127D0 (no) Topiske sammensetninger for behandling av hudsykdom
BR9910465A (pt) Uso de um agente que mantém ou melhora a barreira de permeabilidade da gengiva
RU93055153A (ru) Антибактериальное средство "анальгин"
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/407 (2006.01), A61K 8/49 (2006.0